Abstract:Objective To investigate the level of the thyrotropin recepter antibody (TRAb) in healthy people and patients with different types of thyroid disease,and discuss its clinical significance.Methods Recombinant human thyroid stimulating hormone receptor (TSHR)-ecd N-terminal fragment was used in N method and C-terminal fragment was used in C method as antigens respectively.The serum level of TRAb was measured in 89 healthy people and 254 patients with different types of thyroid disease respectively.The serum levels of TRAb comparison and positive rates comparison between groups were tested by analysis of variance and chi-square test respectively.Results The result of N method:the 405nm light absorption value ((x)±s) in healthy people was 0.511 ±0.135 with a cut-off value ((x)+2s) of 0.789.The positive rate was 4.5％ (4/89).The 405 nm light absorption value((x)±s) in patients with incipient Graves (diffuse toxic goiter) and Hashimoto thyroiditis with hypothyroidism was 0.95±0.30,0.61±0.22 respectively,which was higher than that in healthy people (F=2.4851 and 2.0763,both P＜0.05).The positive rate in incipient Graves disease,Graves disease with treatment,Graves disease patients in convalescence stage and Hashimoto thyroiditis with hypothyroidism was 73.2％,55.9％,32.1％,45.0％,respectively.There were significant differences between the above groups and the normal control group (x2=68.55,56.45,20.71 and 25.51,all P＜0.05).The positive rate was significantly higher in incipient Graves disease patients than Hashimoto thyroiditis with hypothyroidism patients (x2=4.63,P＜0.05).There was significant difference in the positive rate between incipient Graves disease and Graves disease patients in convalescence stage (x2=15.94,P＜0.05).The result of C method:the 405 nm light absorption value ((x)±s) in healthy people was 0.507±0.142 with a cut-off value((x)+2s) of 0.791.The positive rate was 3.4％ (3/89).The 405 nm light absorption value((x)±s) in Hashimoto thyroiditis with hypothyroidism patients and incipient Graves disease patients was 1.18±0.25,0.78±0.25,respectively,which was significantly higher than that in healthy people (F=3.8164,2.4539,P＜0.05).The positive rate in Hashimoto thyroiditis with hypothyroidism,incipient Graves disease,Graves disease with treatment,Graves disease patients in convalescence stage was 75.0％,46.3％,23.6％,16.1％,respectively.There were significant differences among the above groups and the normal control group ((x)=66.34,36.87,15.79,7.30,all P＜0.05).The positive rate was significantly higher in Hashimoto thyroiditis with hypothyroidism than other groups (x2=4.48,19.70,23.68,all P＜0.05).Conclusions The N method and C method had important significance for detecting the serum level of TRAb in Graves disease and Hashimoto thyroiditis with hypothyroidism.It may be used in clinical diagnosis,treatment and curative effect evaluation for Graves disease and Hashimoto thyroiditis with hypothyroidism.

Significance of detection of serum TRAb levels in diagnosis of patients with thyoid disease

The Clinical Application of Human Serum Level of the TRAb Measured by Enzyme-Linked Immunosorbent Assay in Patients with Thyroid Diseases

Clinical Analysis of Serum Level of the TRAb in 1 585 Normal People and Patients with Different Thyroid Diseases

Clinical Study of Serum TRAb in 1 085 Cases of Patients with Thyroid Disease and Normal Adults

Study on the detection value of thyroid function and related antibody in Graves disease

The Changes of the Shear Wave Velocities on Thyroid Tissues in Patients with Graves Disease and Its Correlation with Thyrotropin

Diagnostic value of thyroid autoantibodies in Graves' disease

Study on thyrotropin receptor autoantibody in female patients with autoimmune thyroid disease determined by using recombinant human TSH receptor ectodomain

Experimental study on abnormal thyroid function in patients with Hashimoto's thyroiditis caused by interference of thyroid hormone autoantibodies

The Expression of Human Thyrotropin Receptor and the Detection of Thyrotropin Receptor Antibody

The Clinical Application of A New ELISA to Detect Human Thyroid Peroxidase Autoantibody

Serum Ratio of Free Triiodothyronine to Thyroid-Stimulating Hormone: A Novel Index for Distinguishing Graves’ Disease From Autoimmune Thyroiditis

Detection and significance of the alteration of Th17 cells in patients with Hashimoto's thyroiditis and Graves' disease

Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease.

Changes of serum FT3, FT4, sTSH, TRAb, TGA and TMA concentrations in Graves' patients treated with 131I and clinical significances

Establishment of an Indirect ELISA Using Recombinant Human Thyroglobulin for Detecting TgAb and Its Preliminary Application

Clinical Evaluation of Various Thyroid Hormones on Thyroid Function

Detection of thyroid autoantibodies and autologous serum skin test in patients with chronic urticaria

Role of serum thyroglobulin levels in differentiating hyperthyroidism and thyrotoxic phases of thyroiditis

A novel human TSHR antibody ELISA using recombinant extracellular domain fragments of human TSH receptor as antigen and initial clinical evaluation

Consistency Between Thyrotropin Receptor Antibody (TRAb) and Thyroid-Stimulating Antibody (TSAb) Levels in Patients with Graves Disease.